Roundtable 4: Effectively Scaling Cell Therapies of the Future by Optimizing Flexible Manufacturing Practices for High-throughput Capacity and Affordable Patient Accessibility

Key Talking Points 

• Considerations for optimizing both centralized and decentralized cell therapy manufacturing
• Correctly scaling manufacturing is often thought of as up and out, but, what about down and the criticality of that flexibility?
• Building for capacity starts with simplification and elimination of unnecessary complexities and risks
• When is the right time to address and add automation
• Weighing the impacts of “all-in-one” solutions against the flexibility of a modular and flexible one-size-fits-all approach
• Beginning with the end in mind – the patient and accessibility – a future mindset for scalable growth

Moderated by: Jenny Stjernberg, Director, Commercial Operations EMEA, ScaleReady